Since the reports of the first cases of COVID-19, in less than 5 years, a huge number of
documents regarding that disease and the coronavirus (SARS-CoV-2), responsible for the …

Introduction Epidemiological modeling is widely used to offer insights into the COVID-19
pandemic situation in Asia. We reviewed published computational (mathematical/simulation) …

Ibuzatrelvir (1) was recently disclosed and patented by Pfizer for the treatment of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has received fast-track status …

Abstract The coronavirus disease (COVID‐19), which the World Health Organization
classified as the Sixth Public Health Emergency Of International Concern (PHEIC) on …

Since late 2019, the new SARS-CoV-2 virus belonging to the Coronaviridae family has been
responsible for COVID-19 pandemic, a severe acute respiratory syndrome. Several antiviral …

Populations identified to be severely affected by COVID-19, such as pregnant patients,
require special consideration in vaccine counseling, access, and provider education …

The COVID-19 pandemic was the most significant public healthcare crisis worldwide. It was
estimated that 80% of infected patients with COVID-19 have not fully recovered and …

Background Due to COVID-19, pandemic preparedness emerges as a key imperative,
necessitating new approaches to accelerate development of reagents against infectious …

Excipients are ingredients in pharmaceutical products other than the active ingredient,
added to facilitate manufacturing, enhance stability or modulate release and bioavailability …

Abbreviations: MMR, measles-mumps-rubella; ICU, intensive care unit; ACE2, angiotensin
converting enzyme 2 receptor; CDC, Centers for Disease Control and Prevention; SGA …